Anthony John Day - Selected publications#
1. Banerji S, Wright AJ, Noble M*, Mahoney DJ, Campbell ID, Day AJ* & Jackson DG* Structures of the CD44-hyaluronan complex and new insight into a fundamental carbohydrate-protein interaction. (2007) Nat. Struct. Mol. Biol. 14, 234-239. *Co-corresponding author. Paper featured at Functional Glycomics Gateway: http://www.functionalglycomics.org/fg/update/2007/070412/full/fg.2007.13.shtml
2. Forteza R*, Casalino-Matsuda S, Monzon-Medina ME, Rugg MS, Milner CM & Day, AJ* TSG-6 potentiates the anti tissue kallikrein activity of inter-α-inhibitor through bikunin release. (2007) Am. J. Resp. Cell Mol. 36, 20-31. With journal cover illustration
3. Prosser BE, Johnson S, Roversi P, Herbert AP, Blaum BS, Tyrrell J, Jowitt TA., Clark SJ, Tarelli E, Uhrin D, Barlow PN, Sim RB, Day AJ* & Lea SM* Structural basis for complement factor H linked age-related macular degeneration. (2007) J. Exp. Med. 204, 2277-2283. Paper featured at Functional Glycomics Gateway: http://www.functionalglycomics.org/fg/update/2007/071108/full/fg.2007.47.shtml
4. Robinson DE, Marson A, Short RD*, Buttle DJ, Day AJ*, Parry P, Wiles M, Highfield P, Mistry A & Whittle J. Surface gradient of functional heparin. (2008) Advanced Materials 20, 1166-1169.
5. Mahoney DJ, Mikecz K, Ali T, Mabilleau G, Benayahu D, Plaas A, Milner CM*, Day AJ* & Sabokbar A* TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation. (2008) J. Biol. Chem. 283, 25952-25962. Press release: http://www.manchester.ac.uk/aboutus/news/archive/list/item/?id=4000&year=2008&month=09
6. Clark SJ, Perveen R, Hakobyan S, Morgan BP, Sim RB, Bishop PN* & Day AJ* Impaired binding of age-related macular degeneration-associated complement factor H 402H allotype to Bruch’s membrane in human retina. (2010) J. Biol. Chem. 285, 30192-30202. New Scientist (2nd October 2010; p15): Leading Cause of Blindness Solved
7. Inforzato A, Baldock C, Jowitt TA, Holmes DF, Lindstedt R, Marcellini M, Rivieccio V, Briggs DC, Kadler KE, Verdoliva A, Bottazzi B, Mantovani A, Salvatori G & Day AJ* The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2. (2010) J. Biol. Chem. 285, 17681-17692.
8. Mahoney DJ, Swales C, Athanasou NA, Bombardieri M, Pitzalis C, Kliskey K, Sharif M, Day AJ*, Milner CM* & Sabokbar A* TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with OPG. (2011) Arthritis Rheum. 63, 1034-1043.
9. Baranova NS, Nilebäck E, Briggs DC, Haller MF, Svedhem S, Day AJ* & Richter RP* The inflammation-associated protein TSG-6 cross-links hyaluronan via hyaluronan-induced TSG-6 oligomers. (2011) J. Biol. Chem. 286, 25675-25686.
10. Leali D, Inforzato A, Ronca R, Bianchi R, Belleri M, Coltrini D, Di Salle E, Sironi M, Danilo G, Bottazzi B, Garlanda C, Day AJ* & Presta M* (2012) Long pentraxin 3/TSG-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis. Arterioscl. Throm. Vas. 32, 696-703.
